NDVA.V · Indiva Limited

-

Please sign in to comment on NDVA.V

1 Comment

Admin

3 years, 7 months ago

Indiva Limited is currently in a long term downtrend where the price is trading 7.4% below its 200 day moving average.

From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.6.

Indiva Limited's total revenue rose by 1531.6% to $3M since the same quarter in the previous year.

Its net income has dropped by 36.0% to $-4M since the same quarter in the previous year.

Finally, its free cash flow fell by 56.6% to $-5M since the same quarter in the previous year.

Based on the above factors, Indiva Limited gets an overall score of 2/5.

ISIN	CA45580J1012
Sector	Healthcare
Industry	Drug Manufacturers-Specialty & Generic
CurrencyCode	CAD
Exchange	V

Beta	1.72
Target Price	0.3
PE Ratio	None
Market Cap	12M
Dividend Yield	0.0%

ABOUT

Indiva Limited

Indiva Limited engages in the production, processing, and sale of cannabis and cannabis related products in Canada. It offers pre-rolls, flower, capsules, and edible and extract products under the INDIVA and Artisan Batch brands, as well as provides production and manufacturing services to peer entities. The company produces and distributes the Bhang Chocolate, Wana Sour Gummies, Slow Ride Bakery Cookies, Jewels Chewable Tablets, Ruby Cannabis Sugar, Grön edibles, and Dime Industries vape products through license agreements and partnerships. Indiva Limited is based in Ottawa, Canada.

NDVA.V · Indiva Limited

-

Indiva Limited

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Indiva Limited using a moving average strategy